Everads Presents Clinical Data from First-in-Human Trial of Suprachoroidal Delivery Technology at EURETINA ...Middle East

- 1st cohort data demonstrates safety, feasibility and tolerability of the Everads Injector for delivering drugs to the back of the eye via the suprachoroidal space - Results validate use of the Injector in a clinical, office-based setting, and will support the clinical trial applications...

Hence then, the article about everads presents clinical data from first in human trial of suprachoroidal delivery technology at euretina was published today ( Thursday 19/09/2024 - 12:13 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Everads Presents Clinical Data from First-in-Human Trial of Suprachoroidal Delivery Technology at EURETINA )

Also on site :

• Zelensky-linked drone plant hit – Russian MOD
• More graft uncovered at state giant allegedly co-opted by ‘Zelensky’s wallet’
• Mubi Fest Returning To Chicago With ‘Teenage Sex & Death at Camp Miasma’